Capecitabine Comfort vs ADC Leap Dr. Mouabbi voices the field’s discomfort with bypassing capecitabine after DB-06 made it the comparator arm. Dr. Cairo counters that capecitabine is “endocrine adjacent” but may fail the rapid progressors who really need an ADC first. FacebookXRedditPinterestEmail You may also like Video Dr. Jason Mouabbi & Dr. Michelina Cairo – Talking DB04 and DB06 2 min read Video Concurrent Endocrine: Old-School? 1 min read Video DB-04 to DB-06, the Steps of Ultra-Low 1 min read Video Ultra-Low in Real Life 1 min read Video Any HER2 Ever? 1 min read Video First-Strike 1 min read Recommended Videos Rethinking First-Line Metastatic HER2+ Therapy with T-DXd – Drs. Mouabbi, O’Shaughnessy & Rimawi 4 months ago Is T-DXd Rewriting First-Line HER2+ Metastatic Breast Cancer? – Dr. Mark Pegram & Dr. Fengting Yan 4 months ago Is HER2+ Metastatic Breast Cancer Curable? What Comes Next – Dr. Gregory Vidal & Dr. Nusayba Bagegni 4 months ago DESTINY-Breast09 & the Future of Care – Dr. Irene Kang & Dr. Aditya Bardia 4 months ago
Rethinking First-Line Metastatic HER2+ Therapy with T-DXd – Drs. Mouabbi, O’Shaughnessy & Rimawi 4 months ago
Is T-DXd Rewriting First-Line HER2+ Metastatic Breast Cancer? – Dr. Mark Pegram & Dr. Fengting Yan 4 months ago
Is HER2+ Metastatic Breast Cancer Curable? What Comes Next – Dr. Gregory Vidal & Dr. Nusayba Bagegni 4 months ago